Published on 2 Nov 2022 on Zacks via Yahoo Finance
Lannett (LCI) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.27 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.70%. A quarter ago, it was expected that this generic drug company would post a loss of $0.46 per share when it actually produced a loss of $0.44, delivering a surprise of 4.35%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.